Currency In USD
| Previous Close | 10.32 |
| Open | 11.02 |
| Day High | 11.02 |
| Day Low | 9.92 |
| 52-Week High | 12.7 |
| 52-Week Low | 4.41 |
| Volume | 101,838 |
| Average Volume | 88,320 |
| Market Cap | 89.44M |
| PE | -5.9 |
| EPS | -1.68 |
| Moving Average 50 Days | 9.26 |
| Moving Average 200 Days | 7.38 |
| Change | -0.4 |
electroCore to Participate at the 38th Annual Roth Conference
GlobeNewswire Inc.
Mar 10, 2026 12:00 PM GMT
ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual Roth Conference March 22-24 at the Ritz-Carlton
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
GlobeNewswire Inc.
Mar 09, 2026 12:00 PM GMT
ROCKAWAY, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended De
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)
GlobeNewswire Inc.
Jan 21, 2026 1:00 PM GMT
ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the Vagus Nerve Society have launched a new research in